About
Our Company

Management

Board of Directors

Scientific Advisory Board

Partners

About TScan

TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.
Technology
Our Approach

TargetScan

ReceptorScan

T-Integrate Cell Engineering

Publications

Technology

TScan’s therapeutic approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not.
Investors and Media
Pipeline
Careers

Unleash immunity

TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.

How We're Different

News

TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones

News

TScan Therapeutics Announces Upcoming Presentations at the 25th American Society of Gene and Cell Therapy Annual Meeting

News

TScan Therapeutics Appoints Leiden Dworak, CPA, MBA, as Vice President, Finance